Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Stroke. 2008 Dec 31;40(3):730–736. doi: 10.1161/STROKEAHA.108.526798

Table 2.

Carotid Artery Intima-Media Thickness (CIMT) Progression by Treatment Group

B-Vitamins (n=248) Placebo (n=242) p-value*
All subjects, adjusted for baseline CIMT strata (<≥0.75 mm) 0.0022 (0.0005) 0.0029 (0.0007) 0.31
Baseline fasting plasma total homocysteine
<9.1 μmol/L (n=126/119) 0.0028 (0.0006) 0.0021 (0.0007) 0.41
≥9.1 μmol/L (n=122/123) 0.0016 (0.0007) 0.0038 (0.0007) 0.02
*

p-values from mixed effects models

Mean (SE) carotid artery intima-media thickness (CIMT) progression rate (mm/year)

Sample sizes in sub-group analysis (B-vitamins/Placebo)